Important update about the Boucherville plant and development center

Following a decision of the Superior Court of Quebec last June to grant Sandoz Canada Inc. the right to regain ownership of the Boucherville manufacturing site and development center, we are pleased to announce that we entered into an agreement with Ernst & Young Inc., as court-appointed Receiver of the assets of Avara Boucherville Pharmaceuticals to re-acquire the site. The transaction will be concluded with the Receiver and is expected to close in January 2020, following the completion of usual and customary closing conditions.

Sandoz Canada is committed to bringing back in the site stable operations management and a rewarding work environment for the employees. Our priority is to continue to supply, without interruption, the hospitals in Canada and in the United States with the high-quality, injectable medicines patients and their healthcare professionals rely on.